Kensington Investment Counsel’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
MC
Kensington Investment Counsel's TECH Position: Q1 2026 in Review
Kensington Investment Counsel sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 7,293 shares — an estimated $429K sold.
Kensington Investment Counsel first reported a position in TECH in Q4 2020 and held it in 20 quarters. The position peaked at $2.51M in Q4 2021. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Kensington Investment Counsel reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
- Kensington Investment Counsel sold 7,293 Bio-Techne shares in Q1 2026, an estimated $429K.
- Kensington Investment Counsel first reported a position in Bio-Techne in Q4 2020 and held it in 20 quarters.
- Kensington Investment Counsel's Bio-Techne position peaked at $2.51M in Q4 2021.
- 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.